---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-024123"
form_type: "8-K"
ticker: "STOK"
cik: "0001623526"
company_name: "Stoke Therapeutics, Inc."
filed_at: "2023-02-03T23:59:59+00:00"
generated_at: "2026-06-20T01:04:03.817023+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Stoke Therapeutics amends bylaws to conform to DGCL and universal proxy rules

## Summary
- Updated provisions on adjournment, stockholder lists, and electronic transmission of notices to align with recent DGCL amendments.
- Revised advance notice bylaws require additional disclosures, limit nominees to board seats up for election, and mandate nominee interviews.
- Added rules to comply with universal proxy (Rule 14a-19): stockholders must certify compliance and provide evidence 5 business days before meeting.
- Requires stockholders soliciting proxies to use a non-white proxy card; authorizes emergency bylaws for quorum issues.
- Effective February 2, 2023; no financial or operational impact disclosed.

## SEC filing metadata
- accession: 0001193125-23-024123
- form_type: 8-K
- ticker: STOK
- cik: 0001623526
- company_name: Stoke Therapeutics, Inc.
- filed_at: 2023-02-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1623526/000119312523024123/0001193125-23-024123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1623526/000119312523024123/d427161d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-024123
- JSON: https://secwatch.observer/filing/0001193125-23-024123.json
- Plain text: https://secwatch.observer/filing/0001193125-23-024123.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.